Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Morning blood draws: No longer required?
By
Gary Milburn, Ph.D.
with William DePond, M.D.
Jan 30, 2013
There is mounting evidence that blood does not need to be drawn prior to eating! Such medical conclusions may change the early morning paradigm and how patients are managed.